Athens QRS score flags false-negative exercise stress tests
Patients with a low Athens QRS score are highly likely to have coronary artery disease even if they have a normal exercise stress test, say researchers. (Source: MedWire News)
Source: MedWire News - June 23, 2016 Category: Consumer Health News Tags: Coronary heart disease Source Type: news
Genetic testing worthwhile in sudden cardiac death
Genetic testing and family screening help to provide explanations for sudden cardiac death in children and young adults, shows a population-based study. (Source: MedWire News)
Source: MedWire News - June 23, 2016 Category: Consumer Health News Tags: Cardiology Source Type: news
Everolimus-eluting bioresorbable vascular scaffold shows promise in PAD
A first-in-human trial of an everolimus-eluting bioresorbable vascular scaffold has shown that the device can achieve a high 2-year patency rate and low 2-year target lesion revascularisation rate in patients with peripheral artery disease involving the external iliac artery and superficial femoral artery. (Source: MedWire News)
Source: MedWire News - June 23, 2016 Category: Consumer Health News Tags: Cardiology Source Type: news
NOACs match warfarin for atrial fibrillation
Real-world study data from Denmark show that non-vitamin K antagonist oral anticoagulants are effective alternatives to warfarin in patients with non-valvular atrial fibrillation in a routine care setting. (Source: MedWire News)
Source: MedWire News - June 23, 2016 Category: Consumer Health News Tags: Cardiology Source Type: news
Pretreatment smoking linked to poor prognosis in AI-treated patients
Among older aromatase inhibitor (AI)-treated patients with breast cancer, current smokers at treatment initiation have an increased risk of breast cancer events and distant metastases, say Swedish researchers. (Source: MedWire News)
Source: MedWire News - June 23, 2016 Category: Consumer Health News Tags: Breast cancer Source Type: news
‘Simple’ model predicts PegIFN response in chronic HBV
Chinese researchers have developed a scoring system based on hepatitis B virus-related clinical parameters to predict response to pegylated-interferon in chronic HBV patients. (Source: MedWire News)
Source: MedWire News - June 22, 2016 Category: Consumer Health News Tags: HBV Source Type: news
HCC predictors identified for chronic HBV patients with newly diagnosed cirrhosis
In patients with chronic hepatitis B virus infection who have been newly diagnosed with cirrhosis, the risk of hepatocellular carcinoma development can be ascertained using several clinical and molecular factors, study findings indicate. (Source: MedWire News)
Source: MedWire News - June 22, 2016 Category: Consumer Health News Tags: HBV Source Type: news
Maternal HBsAg can serve as HBV vertical transmission marker
Two studies have independently identified quantitative hepatitis B surface antigen as a marker to identify pregnant women with chronic hepatitis B virus infection whose infants are at high-risk of infection despite immunoprophylaxis. (Source: MedWire News)
Source: MedWire News - June 22, 2016 Category: Consumer Health News Tags: HBV Source Type: news
Salvage inotuzumab ozogamicin improves ALL outcomes
Compared with standard chemotherapy, treatment with inotuzumab ozogamicin increases the rate of complete remission and allows a higher proportion of patients with relapsed or refractory acute lymphoblastic leukaemia to subsequently receive stem-cell transplantation, research suggests. (Source: MedWire News)
Source: MedWire News - June 21, 2016 Category: Consumer Health News Tags: Leukaemia Source Type: news
Protein-based CHD risk score developed
Researchers have screened over 1000 plasma proteins to develop a predictive score in patients with stable coronary heart disease. (Source: MedWire News)
Source: MedWire News - June 21, 2016 Category: Consumer Health News Tags: Coronary heart disease Source Type: news
Switch to rituximab shows anti-inflammatory effect in relapsing–remitting MS
Rituximab may be an attractive treatment option for patients with relapsing–remitting multiple sclerosis, suggest phase II study findings showing its efficacy in controlling inflammatory activity. (Source: MedWire News)
Source: MedWire News - June 21, 2016 Category: Consumer Health News Tags: Multiple sclerosis Source Type: news
Real-world analysis questions very low LDL targets
Patients treated for hypercholesterolaemia in clinical practice may not derive additional benefit from very intensive statin treatment, say researchers. (Source: MedWire News)
Source: MedWire News - June 21, 2016 Category: Consumer Health News Tags: Cardiometabolic Source Type: news
Apixaban effective in polypharmacy setting
The superiority of apixaban over warfarin in patients with atrial fibrillation is maintained in those taking multiple medications, shows further analysis of the ARISTOTLE trial. (Source: MedWire News)
Source: MedWire News - June 21, 2016 Category: Consumer Health News Tags: Arrhythmia Source Type: news
Persistent low flow warns of mortality risk after TAVR
Patients with persistent low flow at discharge after transcatheter aortic valve replacement have an increased risk of dying during the subsequent year, report researchers. (Source: MedWire News)
Source: MedWire News - June 21, 2016 Category: Consumer Health News Tags: Interventional cardiology Source Type: news
ERCC2 validated as chemotherapy response biomarker in bladder cancer
Somatic mutations in the helicase-encoding ERCC2 gene are associated with response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive urothelial bladder carcinoma. (Source: MedWire News)
Source: MedWire News - June 17, 2016 Category: Consumer Health News Tags: Oncology Source Type: news
